LGVN (LGVN) Stock Price & Analysis
LGVN (LGVN) rose 3.50% to USD 6.81 as of September 8, 2026 at 08:19 UTC, according to Nexqual real-time market data.
LGVN last closed at USD 6.81; the session ranged USD 6.53–6.88 on volume of 41,237 shares. Market capitalization is —, with a 52-week range of USD 4.75–12.3 (NCM). Source: Nexqual, September 8, 2026 at 08:19 UTC.
Key Statistics (as of September 8, 2026 at 08:19 UTC)
| Price | USD 6.81 |
|---|---|
| Change | ▲ 3.50% (up) |
| Previous Close | USD 6.81 |
| Open | USD 6.81 |
| Day Range | USD 6.53 – 6.88 |
| 52-Week Range | USD 4.75 – 12.3 |
| Volume | 41,237 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (LGVN)
Nexqual's technical model rates LGVN "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 08:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 48.09 (neutral) |
| vs SMA50 | Below (USD 6.91) |
| MACD | -0.11 (negative) |
From LGVN's Latest SEC 10-K Filing (filed 2026-03-17)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ISPC | iSpecimen Inc. | USD 1.54 | ▲ 3.36% |
| BFRI | Biofrontera Inc. | USD 1.61 | ▲ 5.92% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 20% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.46 | ▲ 2.93% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.58 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:19 UTC. This page is informational and not investment advice.